PI Health Sciences Financial Overview
Solid Balance Sheet: result of sustained internal accruals, efficient NWC
management and disciplined capital allocation
Fig in Rs. Million
Shareholders Fund
Pi
Inspired by Science
-
Highlights of 9MFY24
Net fixed asset increase by Rs. 7,821 million Y-o-Y.
Total capex for 9MFY24 is Rs. 9,001 million including Pharma¹ acquired
assets of Rs 4,972 million. The capex excluding this addition is Rs. 4,029
million (9MFY23 Rs. 2,585 million).
Increase in Other assets includes long term fixed deposits of Rs. 658
million.
Trade working capital in terms of Days of Sales improved to 80 days as
on 31-Dec-23 vs. 90 days as on 31-Dec-22.
Inventory levels of Rs. 12,743 million and Rs. 11,878 million excluding
Pharma¹, reduced in terms of Days of Sales to approx. 59 days to vs. 81
days as on 31-Dec-22.
Surplus cash net of debt is Rs. 32,926 million.
Dec-23
84,508
Mar-23
71,985
Dec-22
69,716
◉
Non Current Liabilities
3,082
994
2,233
Long term borrowings
697
1,056
Other long term liabilities
2,385
994
1,077
Current liabilities
16,521
11,818
14,209
Short term borrowings
1,004
1,089
Trade payables
10,476
8,380
9,459
Other current liabilities
5,041
3,438
3,661
Total
1,04,111
84,797
86,158
Non Current Asset
39,131
28,174
27,393
Net Fixed Asset
33,633
26,551
25,812
Goodwill
3,618
828
828
Non current investments
872
313
301
Other assets
1,009
482
452
Current Assets
64,980
56,623
58,765
Inventories
12,743
13,976
14,517
Trade receivables
Cash, Bank & Investments
15,099
8,381
11,156
34,045
32,272
31,019
Other assets
3,092
1,994
2,073
Total
1,04,111
84,797
86,158
Key Ratios (%) Annualised
Net Sales to Trade Working Capital
4.55
4.64
4.05
Debt/Equity Ratio
0.02
Nil
0.03
Net Sales to Net Fixed Assets
2.35
2.45
2.54
2
ROCE
31.7%
34.6%
31.9%
1 Pharma: Pl Health Sciences Ltd. ("PIHSL") Consolidated including overseas subsidiaries
2 ROCE computed excluding Cash, Bank & Investments
6View entire presentation